Project Grant HT94252410582
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$707K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
Sloan-Kettering Institute For Cancer Research was awarded a $796,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of July 15, 2023 through July 14, 2026. The grant will support research to develop novel tools to improve responses to DNA-damaging therapeutics in metastatic breast cancer. As the prime recipient, Sloan-Kettering Institute For Cancer Research will leverage its expertise in cancer biology,...
Sloan-Kettering Institute For Cancer Research was awarded a $845,789 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2023 to June 30, 2026. The grant will support research to discover biomarkers and address outcome disparities for prostate cancer through exploiting real-world clinical genomic data. As the prime recipient, Sloan-Kettering Institute For Cancer Research will leverage its expertise...
The Sloan-Kettering Institute for Cancer Research was awarded a $1,295,691 Project Grant on November 1, 2024 under the Military Medical Research and Development (CFDA 12.420) federal grant program, administered by the Defense Health Agency. The funding will support research aimed at "Targeting Hypermethylation to Overcome Cisplatin Resistance in Patients with Relapsed/Refractory Germ Cell Tumors" over a performance period ending on October 31, 2027. As a leading comprehensive cancer...
The Defense Health Agency awarded a $619,500 Project Grant to the Sloan-Kettering Institute for Cancer Research, a non-profit organization in New York, NY. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program and will support research to investigate the immunogenicity and targeting of shared neoantigens in adenoid cystic cancer over a 3-year period from September 1, 2023 to August 31, 2026. The research aims to transform health care for Service...
The Sloan-Kettering Institute for Cancer Research was awarded a $906,740 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop an application for following images of nevi (moles) to detect melanoma. The project will be conducted over a 3-year period from August 1, 2023 to July 31, 2026. Through this federal grant, the Sloan-Kettering Institute, a non-profit research organization, will focus on innovative and impactful...
The Sloan-Kettering Institute for Cancer Research was awarded a $923,999 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on understanding the effects of tobacco smoking on African American patients with lung cancer. The award will support a multi-year research initiative from July 1, 2024 to June 30, 2027. As a non-profit organization focused on cancer research and patient care, Sloan-Kettering Institute for...
The federal Project Grant award of $923,805.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant will fund the "Systematic Functional Dissection of Cancer Cell States in Lung Tumors" research project at the Sloan-Kettering Institute for Cancer Research in New York, NY. The project aims to advance understanding of cancer cell biology and develop novel therapeutic approaches for lung cancer, with...
The Defense Health Agency awarded a $5.18 million project grant to the Sloan-Kettering Institute For Cancer Research to support research exploiting epigenetic vulnerabilities in breast cancers with chromosomal instability. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research and investigate medical solutions for battlefield wounds. Over a four-year period from May...
This $176,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research by the Sloan-Kettering Institute for Cancer Research to investigate the interactions of mitochondrially encoded complex I mutations with hypoxia and antitumor immune response in chromophobe renal cell carcinoma. The research aims to further the understanding of cancer biology and potential therapeutic approaches, with a focus on conditions...
This $664,456 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research. The award will fund a 3-year research project focused on investigating biomarkers of immune response in mismatch repair-deficient (MMR-D) endometrial cancer treated with immune checkpoint blockade and radiation. The research aims to advance the understanding of cancer immunology and develop new...